9924 West 74th Street
United States - Map
SurModics, Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neurovascular, urology, and other markets. The In Vitro Diagnostics segment provides component products and technologies that include protein stabilization reagents, substrates, antigens, and surface coatings for diagnostic immunoassay and molecular tests, and biomedical research applications. SurModics, Inc. markets its technologies and products worldwide through direct sales force consisting of sales professionals. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
|SurModics, Inc.’s ISS Governance QuickScore as of Nov 1, 2015 is 4. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 6; Compensation: 2.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Gary R. Maharaj ,
Chief Exec. Officer, Pres and Director
|Mr. Andrew D.C. LaFrence CPA,
Chief Financial Officer and VP of Fin.
|Mr. Bryan K. Phillips ,
Sr. VP of Legal & HR, Gen. Counsel and Corp. Sec.
|Mr. Charles W. Olson ,
Sr. VP and Gen. Mang. of Medical Device
|Mr. Joseph J. Stich ,
VP and Gen. Mang. of In-Vitro Diagnostics
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|